Walleye Trading’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,988
Closed -$271K 1522
2024
Q4
$271K Buy
1,988
+1,549
+353% +$211K ﹤0.01% 580
2024
Q3
$50.6K Buy
+439
New +$50.6K ﹤0.01% 817
2024
Q2
Sell
-40
Closed -$5.52K 1898
2024
Q1
$5.52K Buy
+40
New +$5.52K ﹤0.01% 1379
2023
Q4
Hold
0
2185
2023
Q1
Hold
0
2138
2022
Q4
Hold
0
2227
2022
Q2
Sell
-6,519
Closed -$611K 2381
2022
Q1
$611K Buy
6,519
+4,573
+235% +$429K ﹤0.01% 631
2021
Q4
$166K Buy
1,946
+1,499
+335% +$128K ﹤0.01% 1333
2021
Q3
$43K Sell
447
-2,366
-84% -$228K ﹤0.01% 1446
2021
Q2
$274K Sell
2,813
-454
-14% -$44.2K ﹤0.01% 1009
2021
Q1
$318K Buy
3,267
+1,974
+153% +$192K ﹤0.01% 836
2020
Q4
$124K Sell
1,293
-4,683
-78% -$449K ﹤0.01% 1056
2020
Q3
$575K Buy
+5,976
New +$575K ﹤0.01% 370
2020
Q2
Sell
-32,262
Closed -$2.79M 1578
2020
Q1
$2.79M Buy
32,262
+31,468
+3,963% +$2.72M 0.02% 118
2019
Q4
$85K Buy
+794
New +$85K ﹤0.01% 1049
2019
Q3
Hold
0
1562
2019
Q2
Hold
0
1542
2019
Q1
Sell
-13,400
Closed -$957K 1554
2018
Q4
$957K Buy
13,400
+12,179
+997% +$870K 0.01% 435
2018
Q3
$150K Buy
+1,221
New +$150K ﹤0.01% 1174
2018
Q2
Hold
0
1646
2017
Q2
Sell
-75
Closed -$3 1799
2017
Q1
$3 Buy
+75
New +$3 ﹤0.01% 1564
2016
Q4
Hold
0
2065
2016
Q1
Sell
-100
Closed -$6K 2260
2015
Q4
$6K Buy
+100
New +$6K ﹤0.01% 1699
2015
Q3
Sell
-200
Closed -$10K 2235
2015
Q2
$10K Buy
+200
New +$10K ﹤0.01% 1304